Financials
- Market Capitalization 275.57 M
- Employee 117
- Founded 1999
- CEO N/A
- Website www.niagenbioscience.com
- Headquarter Delaware, United States
- FIGI BBG000BG1J71
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
21
市销率
2.9
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3384 | GLSI Greenwich LifeSciences, Inc. - Common stock | 19.41 USD | -0.67% | -3.91% | -19.46% | +71.62% | 284.90 M USD | ||
| 3390 | EDIT Editas Medicine, Inc. - Common Stock | 2.89 USD | -4.93% | -16.23% | +20.92% | +1.76% | 282.95 M USD | ||
| 3404 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.60 USD | -0.55% | -7.46% | -3.23% | +36.36% | 275.27 M USD | ||
| 3405 | TRDA Entrada Therapeutics, Inc. - Common Stock | 7.01 USD | -1.41% | -2.77% | +7.19% | +0.57% | 272.13 M USD |